Your browser doesn't support javascript.
loading
Obinutuzumab in two patients suffering from immune-mediated thrombotic thrombocytopenic purpura intolerant to rituximab.
Robertz, Judith; Andres, Martin; Mansouri Taleghani, Behrouz; Koneth, Irene; Binet, Isabelle; Kremer Hovinga, Johanna A.
Affiliation
  • Robertz J; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Andres M; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Mansouri Taleghani B; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Koneth I; Nephrology and Transplantation Medicine, Kantonsspital St. Gallen, Sankt Gallen, Switzerland.
  • Binet I; Nephrology and Transplantation Medicine, Kantonsspital St. Gallen, Sankt Gallen, Switzerland.
  • Kremer Hovinga JA; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Am J Hematol ; 94(10): E259-E261, 2019 10.
Article in En | MEDLINE | ID: mdl-31321811
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Purpura, Thrombotic Thrombocytopenic / Antibodies, Monoclonal, Humanized Type of study: Diagnostic_studies / Etiology_studies Language: En Journal: Am J Hematol Year: 2019 Type: Article Affiliation country: Switzerland
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Purpura, Thrombotic Thrombocytopenic / Antibodies, Monoclonal, Humanized Type of study: Diagnostic_studies / Etiology_studies Language: En Journal: Am J Hematol Year: 2019 Type: Article Affiliation country: Switzerland